Fortress Biotech
FBIO
40 hedge funds and large institutions have $17.7M invested in Fortress Biotech in 2015 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 6 closing their positions.
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
3% more funds holding
Funds holding: 39 → 40 (+1)
5% less capital invested
Capital invested by funds: $18.6M → $17.7M (-$912K)
21% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 14
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$174K |
| 2 |
D.E. Shaw & Co
New York
|
+$114K |
| 3 |
Bank of New York Mellon
New York
|
+$70.4K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$69.1K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$41.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EM
Elliott Management
New York
|
-$1.93M |
| 2 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
-$607K |
| 3 |
EGA
Eagle Global Advisors
Houston,
Texas
|
-$83.9K |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$48.3K |
| 5 |
Millennium Management
New York
|
-$42K |
FBIO Hedge Fund Activity: Q4 2015 in Review
40 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q4 2015, worth a combined $17.7M — down 4.9% from $18.6M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new FBIO positions and 6 closed out — a net gain of 1 holder — while 11 added to existing stakes and 14 trimmed.
The largest buyer was Avoro Capital Advisors, adding an estimated $174K. The largest seller was Elliott Management, cutting an estimated $1.93M.
- 40 institutional investors held Fortress Biotech (FBIO) as of Q4 2015, up from 39 in Q3 2015.
- Funds reported $17.7M of Fortress Biotech stock for Q4 2015, down 4.9% quarter-over-quarter.
- 7 funds opened new Fortress Biotech positions in Q4 2015 and 6 closed out, a net change of +1 holder.
- The largest Fortress Biotech buyer in Q4 2015 was Avoro Capital Advisors, an estimated $174K added.
- The largest Fortress Biotech seller in Q4 2015 was Elliott Management, an estimated $1.93M sold.
Based on aggregated 13F filings for Q4 2015.